Sonic Healthcare Ltd (SKHCF) 16.3900 $SKHCF
Medivo Appoints Clinical Lab Industry Leader David Bryant to Advisory Board
PRWeb - Thu Aug 21, 7:10AM CDT
Medivo, Inc., a leader in lab data and healthcare analytics, has appointed clinical lab industry leader David W. Bryant to its Advisory Board, which represents a panel of recognized leaders in the life science and health information technology sectors who provide strategic guidance to the company.
2014 Clinical Laboratory Services Global Strategic Business Report - Despite Challenges, Emerging Markets Provide Growth Opportunities
M2 - Tue Mar 11, 6:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/tt3zfb/clinical) has announced the addition of the "Clinical Laboratory Services - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Clinical Laboratory Services in US$ Million by the following Product Segments: Hospital-Based Laboratories, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2012 through 2020. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Key Topics Covered I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. EXECUTIVE SUMMARY 1. INDUSTRY OVERVIEW 2. COMPETITIVE LANDSCAPE 3. CLINICAL LABORATORY SERVICES - AN INTRODUCTION 4. PRODUCT INNOVATIONS/INTRODUCTIONS - Genomic Health Launches Oncotype DX Prostate Cancer Test - Clarient Rolls Out Next-Generation Sequencing Assay - SilverStaff Clinical Laboratories to Provide BGM Galectin-3® Test of BG Medicine - Quest Diagnostics Unveils Dementia Clinical Diagnostic Panel - Psychemedics Unveils Hair Alcohol Test - Prometheus Laboratories Introduces PROMETHEUS® Anser ADA - NeoGenomics Launches Clinical Molecular Tests for MDS - LipoScience Introduces Vantera Clinical Analyzer for Cardiovascular Disease Management - Atherotech Diagnostics Lab Introduces AspirinWorks® Test - GeneDx to Introduce Comprehensive Genetic Tests Suite for Ovarian and Breast Cancers - Enzo Clinical Labs Collaborates with Oncimmune to Launch Novel Diagnostic Test - Myriad RBM Introduces Oncology® v. 2.0 Test - NeoGenomics Introduces NeoSITE Barrett's Esophagus FISH Test - diaDexus Introduces CE marked PLAC Test for Lp-PLA(2) Activity 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT PLAYERS 7. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. LATIN AMERICA 7. REST OF WORLD IV. COMPETITIVE LANDSCAPE Companies Mentioned The report profiles164 companies including many key and niche players such as: - ADICON Clinical Laboratories - ARUP Laboratories - Asuragen - Atherotech Diagnostics Lab - Bio-Reference Laboratories - Bioscientia Institut f?r Medizinische Diagnostik - Clarient - DaVita - Enzo Clinical Labs - Gaoxin - Da an Health Investment - Gamma-Dynacare Medical Laboratories - Genoptix Medical Laboratory - Genova Diagnostics - Kingmed Diagnostics - Healthscope - Laboratory Corporation of America - Labco - Mayo Medical Laboratories - Myriad Genetic - Pathology - Prometheus Laboratories - Quest Diagnostics) - Sonic Healthcare - American Esoteric Laboratories - Spectra Laboratories - Thyrocare Technologies - The National Health Laboratory Service - Unilabs For more information visit http://www.researchandmarkets.com/research/tt3zfb/clinical About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Concise Analysis of the International Clinical Laboratory Services Market - Forecast to 2019
M2 - Tue Feb 25, 5:36AM CST
Research and Markets (http://www.researchandmarkets.com/research/zt5xj4/clinical) has announced the addition of the "Concise Analysis of the International Clinical Laboratory Services Market - Forecast to 2019" report to their offering. The clinical diagnostic tests performed by laboratories can be broadly classified into four major categories, namely, clinical chemistry, medical microbiology & cytology, human and tumour genetics and other esoteric tests. Ranging from routine blood and urine tests to high-end genetic analysis including fluorescence in situ hybridization (FISH), molecular expression testing etc., clinical laboratories offer numerous tests that help detect disease progression and abnormalities. The three major types of service providers in this market include hospital-based laboratories, clinic-based laboratories and stand-alone laboratories. The global market for clinical laboratory services is expected to record a CAGR of 5.8% during the forecast period of 2013 to 2019, to grow from a USD 162.71 billion market in 2012 to a USD 241.37 billion market in 2019. With the increasing incidence rates of debilitating conditions such as cancer, diabetes and infectious diseases, the number of patients that will opt for such tests will continue to increase in the future and thereby increase the demand for these services. Moreover, the percentage of aged population in the U.S. is expected to grow to an estimated 20% by 2030. Such a large population of elderly people in the U.S. alone will lead to high testing volumes for clinical laboratories. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Clinical Laboratory Services Market, By Test Type, 2011 - 2019 (USD Billion) 5 Global Clinical Laboratory Services Market, By Service Provider, 2011 - 2019 (USD Billion) 6 Global Clinical Laboratory Services Market, By Geography, 2011 - 2019 (USD Billion) 7 Competitive Landscape 8 Recommendations 9 Company Profiles Companies Mentioned: - ARUP Laboratories - Abbott Laboratories - Bio-Reference Laboratories - Bioscientia Healthcare - Charles River Laboratories - Genoptix Medical Laboratory - Healthscope Ltd - Labco SA - Laboratory Corporation Of America Holdings (Labcorp) - Quest Diagnostics, Inc - Sonic Healthcare Limited - Spectra Laboratories For more information visit http://www.researchandmarkets.com/research/zt5xj4/clinical
Drugs of Abuse Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018
M2 - Mon Feb 17, 4:56AM CST
Research and Markets (http://www.researchandmarkets.com/research/nx9bdf/drugs_of_abuse) has announced the addition of the "Drugs of Abuse Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018" report to their offering. Globally, the drugs of abuse testing market is witnessing significant growth due to rising awareness of government and non-government organizations towards ill effects of illicit drugs and to control socio-economical losses associated with drug abuse. As a result, this market is expected to grow during 2013 - 2018. Some of the key driving factors for the drugs of abuse testing market are globally rising consumption of illicit drugs, adoption of drug of abuse (DOA) testing at organizational level, increased production of illicit drugs and their trade and increasing death rates/road accidents due to drug abuse. However, the market faces some restraints such as social concerns associated with illicit drugs testing, legalization of various drugs, and economic volatility and cost concerns. North America, including the US has the largest drugs of abuse testing market and also the fastest growing drugs of abuse testing market. Some of the fastest growing markets for drugs of abuse testing are US, UK, Japan, Germany and other European countries. According to UNODC report 2013, number of illicit drug users is estimated to increase from 167 million in 2009 to 315 million people in 2011. This corresponds to 3.6% to 6.9% of global adult population and cannabis, opioids and opiates were most commonly used illicit drugs. In various countries, including America and European countries, organizations are conducting drug screening test at various levels, such as pre-employment screening, random drug/alcohol screening, post incident drug/alcohol screening and abstinence monitoring. In many countries, government rules & regulations are also supporting the growth of drugs of abuse testing market, as they have outlined essential drug testing at workplace, such as in the US, Japan, Australia and the UK. This has emerged as a key driver for the market. Urine is the largest sample which is diagnosed in the drugs of abuse testing market. The other major samples for drugs of abuse testing are Saliva and Hair. Laboratory drug screening test requires a trained and skilled person to provide an accurate result and involves in-depth analysis. In laboratory screening test, usually the test is reconfirmed using gas chromatography/mass spectrometry or any other superior techniques to provide accurate results. On-site drug screening test gives results on the spot and it is generally preferred for those who take the drug test at home, workplace and educational institutions. The most common specimens used in on-site drug testing are urine, saliva and hair. Nowadays, commercially-available on-site screening test kits are usually designed for urine and saliva specimens only. Roche Diagnostics is the leading player in the global drugs of abuse testing market. Other major players of drugs of abuse testing market include Quest Diagnostics, LabCorp, Alere and Abbott Laboratories and others. Key Topics Covered - Preface - Executive Summary - Drugs of Abuse Testing Market - Industry Analysis - Porter's five force analysis - Global Drugs of Abuse Testing Market - Drugs of Abuse Testing Market - Testing Technology Analysis - Drugs of Abuse Testing Market - Sample Analysis - Single vs. Multiple Parameter Test - Drugs of Abuse Market - Regional Segment Analysis - Recent Developments - Company profiles Companies Mentioned - Abbott Laboratories - Alere - Bio-Rad Laboratories - LabCorp (Laboratory Corporation of America) - Psychemedics Corporation - Quest Diagnostic - Randox Laboratories - Roche Diagnostics - Sonic Healthcare - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/nx...s_of_abuse About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
ACCC to oppose Sonic's acquisition of the assets of Delta Imaging Group
M2 - Fri Jan 17, 3:58AM CST
The Australian Competition and Consumer Commission has announced it will oppose the proposed acquisition by Sonic Healthcare Limited (Sonic) of assets of Delta Imaging Pty Limited (in liquidation), Delta Imaging Maitland Pty Limited (in liquidation) and Cscan Asset Pty Limited (in liquidation) collectively, the Delta Imaging Group.
Global Clinical Laboratory Services Market Report 2013 - 2019
M2 - Fri Dec 20, 6:42AM CST
Research and Markets (http://www.researchandmarkets.com/research/vbxt5s/clinical) has announced the addition of the "Global Clinical Laboratory Services Market Report 2013 - 2019" report to their offering. The report covers the global clinical laboratory services market based on the various categories of tests conducted by laboratories, including clinical chemistry, medical microbiology & cytology, human & tumor genetics and other esoteric tests. The market is also segmented by service providers such as clinic-based, hospital-based and stand-alone laboratories. Geographically, the clinical laboratory services market has been divided into North America, Europe, Asia-Pacific and Rest of the World. The report provides market sizes and forecasts for each segment, sub-segment and geographic region, for 2011-2019 in terms of USD million, with 2012 as the base year. The CAGR % of each market segment, for the forecast period 2013 to 2019, has also been provided. The market overview section of the report presents an elaborate qualitative analysis of the market dynamics, based on factors like drivers, restraints and opportunities. Porter's five force analysis and market attractiveness analysis by geography for the global clinical laboratory services market has also been provided. Key Topics Covered: 1 Introduction 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.4 List of Abbreviations 2 Executive Summary Chapter 3 Market Overview 3.1 Introduction 3.2 Population & Disease Incidence Rate Statistics 3.3 Market Drivers 3.4 Market Restraints 3.5 Market Opportunities 3.6 Porter's Five Forces Analysis: Global Clinical Laboratory Services Market 3.7 Market Attractiveness Analysis: Global Clinical Laboratory Services Market, By Geography, 2012 4 Global Clinical Laboratory Services Market, By Test Type, 2011 - 2019 (USD Billion) 5 Global Clinical Laboratory Services Market, By Service Provider, 2011 - 2019 (USD Billion) 6 Global Clinical Laboratory Services Market, By Geography, 2011 - 2019 (USD Billion) 6.1 Overview 6.2 North America 6.3 Europe 6.4 Asia-Pacific 6.5 Rest Of The World (Row) 7 Competitive Landscape 8 Recommendations 9 Company Profiles Companies Mentioned: - ARUP Laboratories - Abbott Laboratories - Bio-Reference Laboratories - Bioscientia Healthcare - Charles River Laboratories - Genoptix Medical Laboratory - Healthscope Ltd - Labco SA - Laboratory Corporation Of America Holdings (Labcorp) - Quest Diagnostics, Inc - Sonic Healthcare Limited - Spectra Laboratories For more information visit http://www.researchandmarkets.com/research/vbxt5s/clinical
Sonic Healthcare USA Launches Lab Synergy(TM) Hospital Laboratory Program
Marketwire - Mon Jan 28, 7:30AM CST
Sonic Healthcare USA (SHUSA) today announces the launch of a new hospital laboratory program, Lab Synergy(TM), under the leadership of its newly named Vice President of Hospital Affiliations, Noel K. Maring. Lab Synergy leverages the international commercial and hospital laboratory testing expertise of Sonic Healthcare to support health systems in a changing healthcare environment.
Medivo Appoints Clinical Lab Industry Leader David Bryant to Advisory Board
PRWeb - Thu Aug 21, 7:10AM CDT
Medivo, Inc., a leader in lab data and healthcare analytics, has appointed clinical lab industry leader David W. Bryant to its Advisory Board, which represents a panel of recognized leaders in the life science and health information technology sectors who provide strategic guidance to the company.
2014 Clinical Laboratory Services Global Strategic Business Report - Despite Challenges, Emerging Markets Provide Growth Opportunities
M2 - Tue Mar 11, 6:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/tt3zfb/clinical) has announced the addition of the "Clinical Laboratory Services - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Clinical Laboratory Services in US$ Million by the following Product Segments: Hospital-Based Laboratories, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2012 through 2020. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Key Topics Covered I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. EXECUTIVE SUMMARY 1. INDUSTRY OVERVIEW 2. COMPETITIVE LANDSCAPE 3. CLINICAL LABORATORY SERVICES - AN INTRODUCTION 4. PRODUCT INNOVATIONS/INTRODUCTIONS - Genomic Health Launches Oncotype DX Prostate Cancer Test - Clarient Rolls Out Next-Generation Sequencing Assay - SilverStaff Clinical Laboratories to Provide BGM Galectin-3® Test of BG Medicine - Quest Diagnostics Unveils Dementia Clinical Diagnostic Panel - Psychemedics Unveils Hair Alcohol Test - Prometheus Laboratories Introduces PROMETHEUS® Anser ADA - NeoGenomics Launches Clinical Molecular Tests for MDS - LipoScience Introduces Vantera Clinical Analyzer for Cardiovascular Disease Management - Atherotech Diagnostics Lab Introduces AspirinWorks® Test - GeneDx to Introduce Comprehensive Genetic Tests Suite for Ovarian and Breast Cancers - Enzo Clinical Labs Collaborates with Oncimmune to Launch Novel Diagnostic Test - Myriad RBM Introduces Oncology® v. 2.0 Test - NeoGenomics Introduces NeoSITE Barrett's Esophagus FISH Test - diaDexus Introduces CE marked PLAC Test for Lp-PLA(2) Activity 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT PLAYERS 7. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. LATIN AMERICA 7. REST OF WORLD IV. COMPETITIVE LANDSCAPE Companies Mentioned The report profiles164 companies including many key and niche players such as: - ADICON Clinical Laboratories - ARUP Laboratories - Asuragen - Atherotech Diagnostics Lab - Bio-Reference Laboratories - Bioscientia Institut f?r Medizinische Diagnostik - Clarient - DaVita - Enzo Clinical Labs - Gaoxin - Da an Health Investment - Gamma-Dynacare Medical Laboratories - Genoptix Medical Laboratory - Genova Diagnostics - Kingmed Diagnostics - Healthscope - Laboratory Corporation of America - Labco - Mayo Medical Laboratories - Myriad Genetic - Pathology - Prometheus Laboratories - Quest Diagnostics) - Sonic Healthcare - American Esoteric Laboratories - Spectra Laboratories - Thyrocare Technologies - The National Health Laboratory Service - Unilabs For more information visit http://www.researchandmarkets.com/research/tt3zfb/clinical About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Concise Analysis of the International Clinical Laboratory Services Market - Forecast to 2019
M2 - Tue Feb 25, 5:36AM CST
Research and Markets (http://www.researchandmarkets.com/research/zt5xj4/clinical) has announced the addition of the "Concise Analysis of the International Clinical Laboratory Services Market - Forecast to 2019" report to their offering. The clinical diagnostic tests performed by laboratories can be broadly classified into four major categories, namely, clinical chemistry, medical microbiology & cytology, human and tumour genetics and other esoteric tests. Ranging from routine blood and urine tests to high-end genetic analysis including fluorescence in situ hybridization (FISH), molecular expression testing etc., clinical laboratories offer numerous tests that help detect disease progression and abnormalities. The three major types of service providers in this market include hospital-based laboratories, clinic-based laboratories and stand-alone laboratories. The global market for clinical laboratory services is expected to record a CAGR of 5.8% during the forecast period of 2013 to 2019, to grow from a USD 162.71 billion market in 2012 to a USD 241.37 billion market in 2019. With the increasing incidence rates of debilitating conditions such as cancer, diabetes and infectious diseases, the number of patients that will opt for such tests will continue to increase in the future and thereby increase the demand for these services. Moreover, the percentage of aged population in the U.S. is expected to grow to an estimated 20% by 2030. Such a large population of elderly people in the U.S. alone will lead to high testing volumes for clinical laboratories. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Clinical Laboratory Services Market, By Test Type, 2011 - 2019 (USD Billion) 5 Global Clinical Laboratory Services Market, By Service Provider, 2011 - 2019 (USD Billion) 6 Global Clinical Laboratory Services Market, By Geography, 2011 - 2019 (USD Billion) 7 Competitive Landscape 8 Recommendations 9 Company Profiles Companies Mentioned: - ARUP Laboratories - Abbott Laboratories - Bio-Reference Laboratories - Bioscientia Healthcare - Charles River Laboratories - Genoptix Medical Laboratory - Healthscope Ltd - Labco SA - Laboratory Corporation Of America Holdings (Labcorp) - Quest Diagnostics, Inc - Sonic Healthcare Limited - Spectra Laboratories For more information visit http://www.researchandmarkets.com/research/zt5xj4/clinical
Drugs of Abuse Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018
M2 - Mon Feb 17, 4:56AM CST
Research and Markets (http://www.researchandmarkets.com/research/nx9bdf/drugs_of_abuse) has announced the addition of the "Drugs of Abuse Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018" report to their offering. Globally, the drugs of abuse testing market is witnessing significant growth due to rising awareness of government and non-government organizations towards ill effects of illicit drugs and to control socio-economical losses associated with drug abuse. As a result, this market is expected to grow during 2013 - 2018. Some of the key driving factors for the drugs of abuse testing market are globally rising consumption of illicit drugs, adoption of drug of abuse (DOA) testing at organizational level, increased production of illicit drugs and their trade and increasing death rates/road accidents due to drug abuse. However, the market faces some restraints such as social concerns associated with illicit drugs testing, legalization of various drugs, and economic volatility and cost concerns. North America, including the US has the largest drugs of abuse testing market and also the fastest growing drugs of abuse testing market. Some of the fastest growing markets for drugs of abuse testing are US, UK, Japan, Germany and other European countries. According to UNODC report 2013, number of illicit drug users is estimated to increase from 167 million in 2009 to 315 million people in 2011. This corresponds to 3.6% to 6.9% of global adult population and cannabis, opioids and opiates were most commonly used illicit drugs. In various countries, including America and European countries, organizations are conducting drug screening test at various levels, such as pre-employment screening, random drug/alcohol screening, post incident drug/alcohol screening and abstinence monitoring. In many countries, government rules & regulations are also supporting the growth of drugs of abuse testing market, as they have outlined essential drug testing at workplace, such as in the US, Japan, Australia and the UK. This has emerged as a key driver for the market. Urine is the largest sample which is diagnosed in the drugs of abuse testing market. The other major samples for drugs of abuse testing are Saliva and Hair. Laboratory drug screening test requires a trained and skilled person to provide an accurate result and involves in-depth analysis. In laboratory screening test, usually the test is reconfirmed using gas chromatography/mass spectrometry or any other superior techniques to provide accurate results. On-site drug screening test gives results on the spot and it is generally preferred for those who take the drug test at home, workplace and educational institutions. The most common specimens used in on-site drug testing are urine, saliva and hair. Nowadays, commercially-available on-site screening test kits are usually designed for urine and saliva specimens only. Roche Diagnostics is the leading player in the global drugs of abuse testing market. Other major players of drugs of abuse testing market include Quest Diagnostics, LabCorp, Alere and Abbott Laboratories and others. Key Topics Covered - Preface - Executive Summary - Drugs of Abuse Testing Market - Industry Analysis - Porter's five force analysis - Global Drugs of Abuse Testing Market - Drugs of Abuse Testing Market - Testing Technology Analysis - Drugs of Abuse Testing Market - Sample Analysis - Single vs. Multiple Parameter Test - Drugs of Abuse Market - Regional Segment Analysis - Recent Developments - Company profiles Companies Mentioned - Abbott Laboratories - Alere - Bio-Rad Laboratories - LabCorp (Laboratory Corporation of America) - Psychemedics Corporation - Quest Diagnostic - Randox Laboratories - Roche Diagnostics - Sonic Healthcare - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/nx...s_of_abuse About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
ACCC to oppose Sonic's acquisition of the assets of Delta Imaging Group
M2 - Fri Jan 17, 3:58AM CST
The Australian Competition and Consumer Commission has announced it will oppose the proposed acquisition by Sonic Healthcare Limited (Sonic) of assets of Delta Imaging Pty Limited (in liquidation), Delta Imaging Maitland Pty Limited (in liquidation) and Cscan Asset Pty Limited (in liquidation) collectively, the Delta Imaging Group.
Global Clinical Laboratory Services Market Report 2013 - 2019
M2 - Fri Dec 20, 6:42AM CST
Research and Markets (http://www.researchandmarkets.com/research/vbxt5s/clinical) has announced the addition of the "Global Clinical Laboratory Services Market Report 2013 - 2019" report to their offering. The report covers the global clinical laboratory services market based on the various categories of tests conducted by laboratories, including clinical chemistry, medical microbiology & cytology, human & tumor genetics and other esoteric tests. The market is also segmented by service providers such as clinic-based, hospital-based and stand-alone laboratories. Geographically, the clinical laboratory services market has been divided into North America, Europe, Asia-Pacific and Rest of the World. The report provides market sizes and forecasts for each segment, sub-segment and geographic region, for 2011-2019 in terms of USD million, with 2012 as the base year. The CAGR % of each market segment, for the forecast period 2013 to 2019, has also been provided. The market overview section of the report presents an elaborate qualitative analysis of the market dynamics, based on factors like drivers, restraints and opportunities. Porter's five force analysis and market attractiveness analysis by geography for the global clinical laboratory services market has also been provided. Key Topics Covered: 1 Introduction 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.4 List of Abbreviations 2 Executive Summary Chapter 3 Market Overview 3.1 Introduction 3.2 Population & Disease Incidence Rate Statistics 3.3 Market Drivers 3.4 Market Restraints 3.5 Market Opportunities 3.6 Porter's Five Forces Analysis: Global Clinical Laboratory Services Market 3.7 Market Attractiveness Analysis: Global Clinical Laboratory Services Market, By Geography, 2012 4 Global Clinical Laboratory Services Market, By Test Type, 2011 - 2019 (USD Billion) 5 Global Clinical Laboratory Services Market, By Service Provider, 2011 - 2019 (USD Billion) 6 Global Clinical Laboratory Services Market, By Geography, 2011 - 2019 (USD Billion) 6.1 Overview 6.2 North America 6.3 Europe 6.4 Asia-Pacific 6.5 Rest Of The World (Row) 7 Competitive Landscape 8 Recommendations 9 Company Profiles Companies Mentioned: - ARUP Laboratories - Abbott Laboratories - Bio-Reference Laboratories - Bioscientia Healthcare - Charles River Laboratories - Genoptix Medical Laboratory - Healthscope Ltd - Labco SA - Laboratory Corporation Of America Holdings (Labcorp) - Quest Diagnostics, Inc - Sonic Healthcare Limited - Spectra Laboratories For more information visit http://www.researchandmarkets.com/research/vbxt5s/clinical
Sonic Healthcare USA Launches Lab Synergy(TM) Hospital Laboratory Program
Marketwire - Mon Jan 28, 7:30AM CST
Sonic Healthcare USA (SHUSA) today announces the launch of a new hospital laboratory program, Lab Synergy(TM), under the leadership of its newly named Vice President of Hospital Affiliations, Noel K. Maring. Lab Synergy leverages the international commercial and hospital laboratory testing expertise of Sonic Healthcare to support health systems in a changing healthcare environment.
